Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Characterization of Two Novel mAbs Recognizing Different Epitopes on CD43.

Kim S, Hong JW, Cho WD, Moon YR, Yoon SS, Kim MY, Hong KP, Lee YM, Yi JH, Ham YJ, Rah HC, Kim SR, Song HG.

Immune Netw. 2014 Jun;14(3):164-70. doi: 10.4110/in.2014.14.3.164. Epub 2014 Jun 19.

2.

Aberrant glycosylation as biomarker for cancer: focus on CD43.

Tuccillo FM, de Laurentiis A, Palmieri C, Fiume G, Bonelli P, Borrelli A, Tassone P, Scala I, Buonaguro FM, Quinto I, Scala G.

Biomed Res Int. 2014;2014:742831. doi: 10.1155/2014/742831. Epub 2014 Feb 13. Review.

3.

Intracellular patterns of sialophorin expression define a new molecular classification of breast cancer and represent new targets for therapy.

Fu Q, Cash SE, Andersen JJ, Kennedy CR, Madadi AR, Raghavendra M, Dietrich LL, Agger WA, Shelley CS.

Br J Cancer. 2014 Jan 7;110(1):146-55. doi: 10.1038/bjc.2013.526. Epub 2013 Nov 26.

4.

Use of zinc-finger nucleases to knock out the WAS gene in K562 cells: a human cellular model for Wiskott-Aldrich syndrome.

Toscano MG, Anderson P, Muñoz P, Lucena G, Cobo M, Benabdellah K, Gregory PD, Holmes MC, Martin F.

Dis Model Mech. 2013 Mar;6(2):544-54. doi: 10.1242/dmm.010652. Epub 2013 Jan 11.

5.

CD43 regulates the threshold for T cell activation by targeting Cbl functions.

Pedraza-Alva G, Mérida LB, del Rio R, Fierro NA, Cruz-Muñoz ME, Olivares N, Melchy E, Igras V, Holländer GA, Burakoff SJ, Rosenstein Y.

IUBMB Life. 2011 Oct;63(10):940-8. doi: 10.1002/iub.554. Epub 2011 Sep 9.

6.

The cleavage of neutrophil leukosialin (CD43) by cathepsin G releases its extracellular domain and triggers its intramembrane proteolysis by presenilin/gamma-secretase.

Mambole A, Baruch D, Nusbaum P, Bigot S, Suzuki M, Lesavre P, Fukuda M, Halbwachs-Mecarelli L.

J Biol Chem. 2008 Aug 29;283(35):23627-35. doi: 10.1074/jbc.M710286200. Epub 2008 Jun 27.

7.

Signaling through CD43 regulates CD4 T-cell trafficking.

Mody PD, Cannon JL, Bandukwala HS, Blaine KM, Schilling AB, Swier K, Sperling AI.

Blood. 2007 Oct 15;110(8):2974-82. Epub 2007 Jul 16.

8.

Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures.

Vodyanik MA, Thomson JA, Slukvin II.

Blood. 2006 Sep 15;108(6):2095-105. Epub 2006 Jun 6.

9.

CD43 gene expression is mediated by a nuclear factor which binds pyrimidine-rich single-stranded DNA.

Farokhzad OC, Teodoridis JM, Park H, Arnaout MA, Shelley CS.

Nucleic Acids Res. 2000 Jun 1;28(11):2256-67.

10.
11.

Leukosialin (CD43)-major histocompatibility class I molecule interactions involved in spontaneous T cell conjugate formation.

Stöckl J, Majdic O, Kohl P, Pickl WF, Menzel JE, Knapp W.

J Exp Med. 1996 Nov 1;184(5):1769-79.

14.

Altered glycosylation of leukosialin, CD43, in HIV-1-infected cells of the CEM line.

Lefebvre JC, Giordanengo V, Limouse M, Doglio A, Cucchiarini M, Monpoux F, Mariani R, Peyron JF.

J Exp Med. 1994 Nov 1;180(5):1609-17.

15.

Disregulation of leukosialin (CD43, Ly48, sialophorin) expression in the B-cell lineage of transgenic mice increases splenic B-cell number and survival.

Dragone LL, Barth RK, Sitar KL, Disbrow GL, Frelinger JG.

Proc Natl Acad Sci U S A. 1995 Jan 17;92(2):626-30.

16.

The scurfy mouse mutant has previously unrecognized hematological abnormalities and resembles Wiskott-Aldrich syndrome.

Lyon MF, Peters J, Glenister PH, Ball S, Wright E.

Proc Natl Acad Sci U S A. 1990 Apr;87(7):2433-7.

17.
18.

The nucleotide sequence of Ly 48 (mouse leukosialin, sialophorin): the mouse homolog of CD43.

Dorfman KS, Litaker W, Baecher CM, Frelinger JG.

Nucleic Acids Res. 1990 Aug 25;18(16):4932. No abstract available.

19.

Germ-line mosaicism simulates genetic heterogeneity in Wiskott-Aldrich syndrome.

Arveiler B, de Saint-Basile G, Fischer A, Griscelli C, Mandel JL.

Am J Hum Genet. 1990 May;46(5):906-11.

20.

Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow.

Hardy RR, Carmack CE, Shinton SA, Kemp JD, Hayakawa K.

J Exp Med. 1991 May 1;173(5):1213-25.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk